ARA-290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO) that retains its tissue-protective and anti-inflammatory properties without stimulating red blood cell production. It has shown promise in improving nerve health, reducing pain, and supporting tissue repair and recovery.

Potential benefits include:

· Reduces inflammation: ARA-290 helps modulate the body’s inflammatory response, potentially reducing chronic inflammation.

· Promotes nerve repair: It supports regeneration of damaged nerves, offering potential benefits for neuropathic pain and nerve injuries.

· Decreases neuropathic pain: ARA-290 may help alleviate nerve-related pain, including burning or tingling sensations associated with small fiber neuropathy.

· Improves tissue healing: It enhances tissue repair following injury or stress by promoting cellular protection and regeneration.

· Supports immune regulation: ARA-290 may help balance immune activity, reducing overactive immune responses that contribute to chronic inflammation.

· Enhances vascular health: It supports endothelial cell function, improving blood flow and vascular repair.

· Protects against oxidative stress: ARA-290 may reduce oxidative damage in tissues, supporting overall cellular health.

· May improve metabolic function: Some studies suggest ARA-290 can support improved insulin sensitivity and glucose metabolism.

· Potential applications in autoimmune or inflammatory conditions: Its immune-modulating effects may benefit conditions such as sarcoidosis, diabetes-related neuropathy, or autoimmune disorders.